Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Correction: DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance.

Danilov AV, Neupane D, Nagaraja AS, Feofanova EV, Humphries LA, DiRenzo J, Korc M.

PLoS One. 2018 Feb 8;13(2):e0192927. doi: 10.1371/journal.pone.0192927. eCollection 2018.

2.

A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study.

Macy ME, Kieran MW, Chi SN, Cohen KJ, MacDonald TJ, Smith AA, Etzl MM, Kuei MC, Donson AM, Gore L, DiRenzo J, Trippett TM, Ostrovnaya I, Narendran A, Foreman NK, Dunkel IJ.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26621. Epub 2017 May 24.

3.

p53 and ΔNp63α Coregulate the Transcriptional and Cellular Response to TGFβ and BMP Signals.

Balboni AL, Cherukuri P, Ung M, DeCastro AJ, Cheng C, DiRenzo J.

Mol Cancer Res. 2015 Apr;13(4):732-42. doi: 10.1158/1541-7786.MCR-14-0152-T. Epub 2015 Feb 19.

4.

E2F4 regulatory program predicts patient survival prognosis in breast cancer.

Khaleel SS, Andrews EH, Ung M, DiRenzo J, Cheng C.

Breast Cancer Res. 2014 Dec 2;16(6):486. doi: 10.1186/s13058-014-0486-7.

5.

ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer stem cell activity and chemotaxis.

DeCastro AJ, Cherukuri P, Balboni A, DiRenzo J.

Mol Cancer Ther. 2015 Jan;14(1):225-35. doi: 10.1158/1535-7163.MCT-14-0194. Epub 2014 Nov 5.

6.

Clinicopathological correlates of Gli1 expression in a population-based cohort of patients with newly diagnosed bladder cancer.

Sverrisson EF, Zens MS, Fei DL, Andrews A, Schned A, Robbins D, Kelsey KT, Li H, DiRenzo J, Karagas MR, Seigne JD.

Urol Oncol. 2014 Jul;32(5):539-45. doi: 10.1016/j.urolonc.2014.03.006. Epub 2014 May 22.

7.

All-trans-retinoic acid antagonizes the Hedgehog pathway by inducing patched.

Busch AM, Galimberti F, Nehls KE, Roengvoraphoj M, Sekula D, Li B, Guo Y, Direnzo J, Fiering SN, Spinella MJ, Robbins DJ, Memoli VA, Freemantle SJ, Dmitrovsky E.

Cancer Biol Ther. 2014 Apr;15(4):463-72. doi: 10.4161/cbt.27821. Epub 2014 Feb 4.

8.

Oncogenic transformation of mammary epithelial cells by transforming growth factor beta independent of mammary stem cell regulation.

Dunphy KA, Seo JH, Kim DJ, Roberts AL, Tao L, DiRenzo J, Balboni AL, Crisi GM, Hagen MJ, Chandrasekaran T, Gauger KJ, Schneider SS, Jerry DJ.

Cancer Cell Int. 2013 Jul 25;13:74. doi: 10.1186/1475-2867-13-74. eCollection 2013.

9.

Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer.

Ma T, Galimberti F, Erkmen CP, Memoli V, Chinyengetere F, Sempere L, Beumer JH, Anyang BN, Nugent W, Johnstone D, Tsongalis GJ, Kurie JM, Li H, Direnzo J, Guo Y, Freemantle SJ, Dragnev KH, Dmitrovsky E.

Mol Cancer Ther. 2013 Aug;12(8):1545-55. doi: 10.1158/1535-7163.MCT-12-0933. Epub 2013 May 16.

10.

MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transition.

DeCastro AJ, Dunphy KA, Hutchinson J, Balboni AL, Cherukuri P, Jerry DJ, DiRenzo J.

Cell Death Dis. 2013 Feb 28;4:e514. doi: 10.1038/cddis.2013.37.

11.

ΔNp63α-mediated activation of bone morphogenetic protein signaling governs stem cell activity and plasticity in normal and malignant mammary epithelial cells.

Balboni AL, Hutchinson JA, DeCastro AJ, Cherukuri P, Liby K, Sporn MB, Schwartz GN, Wells WA, Sempere LF, Yu PB, DiRenzo J.

Cancer Res. 2013 Jan 15;73(2):1020-30. doi: 10.1158/0008-5472.CAN-12-2862. Epub 2012 Dec 14.

12.

Phosphorylation of ΔNp63α via a novel TGFβ/ALK5 signaling mechanism mediates the anti-clonogenic effects of TGFβ.

Cherukuri P, DeCastro AJ, Balboni AL, Downey SL, Liu JY, Hutchinson JA, DiRenzo J.

PLoS One. 2012;7(11):e50066. doi: 10.1371/journal.pone.0050066. Epub 2012 Nov 16.

13.

Unanticipated reversal of polarity in primary human mammospheres cultured in ultra-low attachment plates.

Dorosko SM, Cherukuri P, Direnzo J.

J Pharm Sci. 2012 Dec;101(12):4666-8. doi: 10.1002/jps.23314. Epub 2012 Sep 10. No abstract available.

14.

DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance.

Danilov AV, Neupane D, Nagaraja AS, Feofanova EV, Humphries LA, DiRenzo J, Korc M.

PLoS One. 2011;6(10):e26815. doi: 10.1371/journal.pone.0026815. Epub 2011 Oct 28. Erratum in: PLoS One. 2018 Feb 8;13(2):e0192927.

15.

ΔNp63α promotes cellular quiescence via induction and activation of Notch3.

Kent S, Hutchinson J, Balboni A, Decastro A, Cherukuri P, Direnzo J.

Cell Cycle. 2011 Sep 15;10(18):3111-8. Epub 2011 Sep 15.

16.

DeltaNp63 transcriptionally regulates ATM to control p53 Serine-15 phosphorylation.

Craig AL, Holcakova J, Finlan LE, Nekulova M, Hrstka R, Gueven N, DiRenzo J, Smith G, Hupp TR, Vojtesek B.

Mol Cancer. 2010 Jul 21;9:195. doi: 10.1186/1476-4598-9-195.

17.

MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors.

Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, Dragnev KH, Li H, Direnzo J, Bak M, Freemantle SJ, Kauppinen S, Dmitrovsky E.

J Clin Invest. 2010 Apr;120(4):1298-309. doi: 10.1172/JCI39566. Epub 2010 Mar 8.

18.

Activation of Hedgehog signaling by the environmental toxicant arsenic may contribute to the etiology of arsenic-induced tumors.

Fei DL, Li H, Kozul CD, Black KE, Singh S, Gosse JA, DiRenzo J, Martin KA, Wang B, Hamilton JW, Karagas MR, Robbins DJ.

Cancer Res. 2010 Mar 1;70(5):1981-8. doi: 10.1158/0008-5472.CAN-09-2898. Epub 2010 Feb 23.

19.

Targeting the cyclin E-Cdk-2 complex represses lung cancer growth by triggering anaphase catastrophe.

Galimberti F, Thompson SL, Liu X, Li H, Memoli V, Green SR, DiRenzo J, Greninger P, Sharma SV, Settleman J, Compton DA, Dmitrovsky E.

Clin Cancer Res. 2010 Jan 1;16(1):109-20. doi: 10.1158/1078-0432.CCR-09-2151. Epub 2009 Dec 22.

20.

Cellular quiescence in mammary stem cells and breast tumor stem cells: got testable hypotheses?

Harmes DC, DiRenzo J.

J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):19-27. doi: 10.1007/s10911-009-9111-2. Epub 2009 Feb 25. Review.

21.

Uncovering growth-suppressive MicroRNAs in lung cancer.

Liu X, Sempere LF, Galimberti F, Freemantle SJ, Black C, Dragnev KH, Ma Y, Fiering S, Memoli V, Li H, DiRenzo J, Korc M, Cole CN, Bak M, Kauppinen S, Dmitrovsky E.

Clin Cancer Res. 2009 Feb 15;15(4):1177-83. doi: 10.1158/1078-0432.CCR-08-1355.

22.

Reciprocal intraepithelial interactions between TP63 and hedgehog signaling regulate quiescence and activation of progenitor elaboration by mammary stem cells.

Li N, Singh S, Cherukuri P, Li H, Yuan Z, Ellisen LW, Wang B, Robbins D, DiRenzo J.

Stem Cells. 2008 May;26(5):1253-64. doi: 10.1634/stemcells.2007-0691. Epub 2008 Feb 21.

23.

Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors.

Li H, Cherukuri P, Li N, Cowling V, Spinella M, Cole M, Godwin AK, Wells W, DiRenzo J.

Cancer Res. 2007 Jan 15;67(2):501-10.

24.

BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.

Nakuci E, Mahner S, Direnzo J, ElShamy WM.

Exp Cell Res. 2006 Oct 1;312(16):3120-31. Epub 2006 Jun 21.

PMID:
16860316
25.

TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53.

Li N, Li H, Cherukuri P, Farzan S, Harmes DC, DiRenzo J.

Oncogene. 2006 Apr 13;25(16):2349-59.

PMID:
16331262
26.

A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma.

Kerley-Hamilton JS, Pike AM, Li N, DiRenzo J, Spinella MJ.

Oncogene. 2005 Sep 8;24(40):6090-100.

PMID:
15940259
27.

Positive and negative regulation of deltaN-p63 promoter activity by p53 and deltaN-p63-alpha contributes to differential regulation of p53 target genes.

Harmes DC, Bresnick E, Lubin EA, Watson JK, Heim KE, Curtin JC, Suskind AM, Lamb J, DiRenzo J.

Oncogene. 2003 Oct 23;22(48):7607-16.

PMID:
14576823
28.

Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line.

DiRenzo J, Signoretti S, Nakamura N, Rivera-Gonzalez R, Sellers W, Loda M, Brown M.

Cancer Res. 2002 Jan 1;62(1):89-98.

29.

Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M.

Cell. 2000 Dec 8;103(6):843-52.

30.

BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation.

DiRenzo J, Shang Y, Phelan M, Sif S, Myers M, Kingston R, Brown M.

Mol Cell Biol. 2000 Oct;20(20):7541-9.

31.

Expression of a subset of steroid receptor cofactors is associated with progesterone receptor expression in meningiomas.

Carroll RS, Brown M, Zhang J, DiRenzo J, Font De Mora J, Black PM.

Clin Cancer Res. 2000 Sep;6(9):3570-5.

32.

P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor.

McMahon C, Suthiphongchai T, DiRenzo J, Ewen ME.

Proc Natl Acad Sci U S A. 1999 May 11;96(10):5382-7.

33.

Segregation of steroid receptor coactivator-1 from steroid receptors in mammary epithelium.

Shim WS, DiRenzo J, DeCaprio JA, Santen RJ, Brown M, Jeng MH.

Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):208-13.

34.

Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4.

Neuman E, Ladha MH, Lin N, Upton TM, Miller SJ, DiRenzo J, Pestell RG, Hinds PW, Dowdy SF, Brown M, Ewen ME.

Mol Cell Biol. 1997 Sep;17(9):5338-47.

35.

Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors.

DiRenzo J, Söderstrom M, Kurokawa R, Ogliastro MH, Ricote M, Ingrey S, Hörlein A, Rosenfeld MG, Glass CK.

Mol Cell Biol. 1997 Apr;17(4):2166-76.

36.

p300 is a component of an estrogen receptor coactivator complex.

Hanstein B, Eckner R, DiRenzo J, Halachmi S, Liu H, Searcy B, Kurokawa R, Brown M.

Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11540-5.

37.

Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding.

Kurokawa R, DiRenzo J, Boehm M, Sugarman J, Gloss B, Rosenfeld MG, Heyman RA, Glass CK.

Nature. 1994 Oct 6;371(6497):528-31.

PMID:
7935766
38.

Regulation of gene expression by retinoic acid receptors.

Glass CK, DiRenzo J, Kurokawa R, Han ZH.

DNA Cell Biol. 1991 Nov;10(9):623-38. Review. No abstract available.

PMID:
1661598
39.

Molecular cloning of protein phosphatase inhibitor-1 and its expression in rat and rabbit tissues.

Elbrecht A, DiRenzo J, Smith RG, Shenolikar S.

J Biol Chem. 1990 Aug 15;265(23):13415-8.

40.

Supplemental Content

Loading ...
Support Center